These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 33484985)

  • 1. Novel treatment modalities for painful diabetic neuropathy.
    Rastogi A; Jude EB
    Diabetes Metab Syndr; 2021; 15(1):287-293. PubMed ID: 33484985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic painful neuropathy: current and future treatment options.
    Chong MS; Hester J
    Drugs; 2007; 67(4):569-85. PubMed ID: 17352515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy.
    Jang HN; Oh TJ
    Diabetes Metab J; 2023 Nov; 47(6):743-756. PubMed ID: 37670573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Treatment of Painful Diabetic Neuropathy.
    Sloan G; Alam U; Selvarajah D; Tesfaye S
    Curr Diabetes Rev; 2022; 18(5):e070721194556. PubMed ID: 34238163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management.
    Tesfaye S; Vileikyte L; Rayman G; Sindrup SH; Perkins BA; Baconja M; Vinik AI; Boulton AJ;
    Diabetes Metab Res Rev; 2011 Oct; 27(7):629-38. PubMed ID: 21695762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tapentadol-ER for the treatment of diabetic peripheral neuropathy.
    Games G; Hutchison A
    Consult Pharm; 2013 Oct; 28(10):672-5. PubMed ID: 24129223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy.
    Zin CS; Nissen LM; Smith MT; O'Callaghan JP; Moore BJ
    CNS Drugs; 2008; 22(5):417-42. PubMed ID: 18399710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis comparing placebo responses in clinical trials of painful HIV-associated sensory neuropathy and diabetic polyneuropathy.
    Kemp HI; Eliahoo J; Vase L; Nguyen S; Ben Abdallah A; Rice ASC; Finnerup NB; Haroutounian S
    Scand J Pain; 2020 Jul; 20(3):439-449. PubMed ID: 32106088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic peripheral neuropathy essentials: a narrative review.
    Chang MC; Yang S
    Ann Palliat Med; 2023 Mar; 12(2):390-398. PubMed ID: 36786097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxcarbazepine for neuropathic pain.
    Zhou M; Chen N; He L; Yang M; Zhu C; Wu F
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD007963. PubMed ID: 29199767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of duloxetine in the management of diabetic peripheral neuropathic pain.
    Smith T; Nicholson RA
    Vasc Health Risk Manag; 2007; 3(6):833-44. PubMed ID: 18200804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review.
    Wong MC; Chung JW; Wong TK
    BMJ; 2007 Jul; 335(7610):87. PubMed ID: 17562735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of transdermal nitric oxide treatment for diabetic peripheral neuropathy and diabetic foot ulcers.
    Walton DM; Minton SD; Cook AD
    Diabetes Metab Syndr; 2019; 13(5):3053-3056. PubMed ID: 30030157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy.
    Desai B; Freeman E; Huang E; Hung A; Knapp E; Breunig IM; McPherson ML; Shaya FT
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):203-9. PubMed ID: 24524594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs.
    Alam U; Sloan G; Tesfaye S
    Drugs; 2020 Mar; 80(4):363-384. PubMed ID: 32040849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on Treating Painful Diabetic Peripheral Neuropathy: A Review of Current US Guidelines with a Focus on the Most Recently Approved Management Options.
    Mallick-Searle T; Adler JA
    J Pain Res; 2024; 17():1005-1028. PubMed ID: 38505500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of diabetic peripheral neuropathy: a review.
    Khdour MR
    J Pharm Pharmacol; 2020 Jul; 72(7):863-872. PubMed ID: 32067247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purinergic P2X receptors and diabetic neuropathic pain.
    Shi L; Zhang HH; Hu J; Jiang XH; Xu GY
    Sheng Li Xue Bao; 2012 Oct; 64(5):531-42. PubMed ID: 23090494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical capsaicin for the management of painful diabetic neuropathy: a narrative systematic review.
    Goodwin B; Chiplunkar M; Salerno R; Coombs K; Sannoh U; Shah V; Averell N; Al-Shebab U; Janora D
    Pain Manag; 2023 May; 13(5):309-316. PubMed ID: 37435696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Treatment of Diabetic Peripheral Neuropathy: An Update.
    Rafiullah M; Siddiqui K
    CNS Neurol Disord Drug Targets; 2022; 21(10):884-900. PubMed ID: 33655879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.